Scleral Lens Market Share

North American Market Forecast

North America industry is set to dominate majority revenue share of 37% by 2037. Because of the expansion of well-established manufacturers' product lines and the growth in the number of scleral lens patients, North America is projected to gain a significant share in the market.

Moreover, the prevalence of eye related diseases in the regional nations is rising, and major key players are working together more closely to support the scleral lens market's expansion. Refractive vision diseases affect a sizable segment of the patient population in North America, especially in the US. This adds to the region’s significant market share, along with easier accessibility to eye care services.

Additionally, there is an increase in demand for scleral lenses as a result of customers becoming more aware of their advantages. 2.3 million Americans are blind today, and by 2030, that number is predicted to rise to 2.2 million. Five million Americans are expected to have reduced eyesight by 2030, up from the current 2.9 million.

APAC Market Statistics

The Asia Pacific scleral lens market is estimated to grow at a highest CAGR in the given time frame. The Asia Pacific region's growing patient base for radial keratotomy and post-LASIK operations has increased demand for sophisticated eye care products, such as scleral lenses. After these refractive operations, patients may have better vision and comfort with scleral lenses. The Asia Pacific area has seen a rise in the use of scleral lenses as a result of patients' and eye care professionals' growing understanding of their advantages.